Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11858980 Engineered polypeptides and uses thereof

Patent 11858980 was granted and assigned to Visterra Inc. on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Brian Booth0

Boopathy Ramakrishnan0

Andrew M. Wollacott0

Kristin Narayan0

Karthik Viswanathan0

Date of Patent

January 2, 2024

0

Patent Application Number

156673090

Date Filed

August 2, 2017

0

Patent Citations

US Patent 7355008 Identification and engineering of antibodies with variant Fc regions and methods of using same

0

US Patent 7371826 Polypeptide variants with altered effector function

0

US Patent 7416727 Polypeptide variants with altered effector function

0

US Patent 7658921 Molecules with extended half-lives, compositions and uses thereof

0

US Patent 7670600 Molecules with extended half-lives, compositions and uses thereof

0

US Patent 7704497 Molecules with extended half-lives, compositions and uses thereof

0

US Patent 7785791 Polypeptide variants with altered effector function

0

US Patent 7790858 Polypeptide variants with altered effector function

0

...

Patent Primary Examiner

0

Patent abstract

Polypeptides, such as antibody molecules and fusion proteins, comprising an Fc region, are disclosed. The polypeptides can be used to treat, prevent, and/or diagnose disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11858980 Engineered polypeptides and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool